Close Menu

chlamydia

NEW YORK (GenomeWeb News) – Once the $3.7 billion Hologic acquisition of Gen-Probe is completed, Gen-Probe will become the "hub" of Hologic's diagnostics business, and in addition to selling the San Diego company's

NEW YORK (GenomeWeb News) – Cepheid this week updated its test pipeline with a focus on gonorrhea and chlamydia, cancer, and tuberculosis over the next few years.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Gen-Probe's Panther, a fully automated and integrated molecular testing platform, the San Diego-based company announced today.

Hologic's planned $3.7 billion acquisition of Gen-Probe, announced earlier this week, is expected to create the largest diagnostics company focused on women's health, according to Hologic officials.

By Ben Butkus
Gen-Probe this week reported record revenues of $158.2 million in the fourth quarter of 2011, driven primarily by sales of clinical diagnostics and blood screening products.

Roche said this week that its Cobas CT/NG test for Chlamydia trachomatis and Neisseria gonorrhoeae infections has received 510(k) clearance from the US Food and Drug Administration.

NEW YORK (GenomeWeb News) – Roche today announced its cobas CT/NG Test for Chlamydia trachomatis and Neisseria gonorrhoeae infections has received 510(k) clearance from the US Food and Drug Administration.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.